Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
Authors:
- Petra van der GroepPGPetra van der Groep
- Alwin BouterABAlwin Bouter
- Richard van der ZandenRZRichard van der Zanden
- Fred H. MenkoFMFred H. Menko
- Horst BuergerHBHorst Buerger
- Rene H.M. VerheijenRVRene H.M. Verheijen
- Elsken van der WallEWElsken van der Wall
- van DiestVDvan Diest
- Paul J.PJPaul J.
Open Access
- 4 May 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 96 (9) , 712-713
Abstract
Foulkes et al. (1) reported that the expression of cytokeratin 5/6, indicating a basal epithelial phenotype, was statistically significantly associated with germline BRCA1 mutations in estrogen receptor (ER)- and erbB2-negative invasive breast cancers. It has recently been shown that the epidermal growth factor receptor (EGFR) is often expressed in basal-type (“stem”) cells of the breast (2), extending the phenotype of basal cells to ER−/erbB2−/EGFR+ breast cells. We examined the expression of EGFR by immunohistochemistry in the invasive breast cancers from 21 proven carriers of BRCA1 germline mutations and five proven carriers of BRCA2 germline mutations, as well as from a control group of 430 invasive breast cancers from patients unselected for a family history of breast cancer. Only clear membrane staining for EGFR was considered as overexpression. Of the 21 BRCA1-related breast cancers, 14 (67%) showed EGFR overexpression, 19 (90%) were ER negative, and 17 (81%) were erbB2 negative. Eleven (52%) of 21 tumors were ER−/erbB2−/EGFR+.Keywords
This publication has 4 references indexed in Scilit:
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI: Journal of the National Cancer Institute, 2003
- Molecular classification of familial non- BRCA1/BRCA2 breast cancerProceedings of the National Academy of Sciences, 2003
- Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast CarcinogenesisLaboratory Investigation, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002